The CRF peptide family and their receptors: yet more partners discovered.

[1]  J. Vaughan,et al.  Corticotropin-Releasing Factor (CRF) Family of Ligands and Their Receptors , 2004 .

[2]  R. Hauger,et al.  Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells , 2001, Peptides.

[3]  G. Cantarella,et al.  Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors , 2001, British journal of pharmacology.

[4]  Y. Matsumoto,et al.  Corticotropin releasing hormone stimulates proliferation of keratinocytes. , 2001, Life sciences.

[5]  J. Licinio,et al.  Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls , 2001, Molecular Psychiatry.

[6]  N. Kalin,et al.  Persistent corticotropin-releasing factor(1) receptor desensitization and downregulation in the human neuroblastoma cell line IMR-32. , 2001, Brain research. Molecular brain research.

[7]  J. Mazurkiewicz,et al.  Cutaneous expression of corticotropin‐releasing hormone (CRH), urocortin, and CRH receptors , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  C. Donaldson,et al.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  K. Takahashi,et al.  Urocortin in the synovial tissue of patients with rheumatoid arthritis. , 2001, Clinical science.

[10]  G. Aguilera,et al.  Regulation of pituitary corticotropin releasing hormone receptors , 2001, Peptides.

[11]  A. Hsueh,et al.  Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor , 2001, Nature Medicine.

[12]  R. Hauger,et al.  Molecular biology of the CRH receptors— in the mood , 2001, Peptides.

[13]  H. Randeva,et al.  The role of corticotropin-releasing hormone receptors in placenta and fetal membranes during human pregnancy. , 2001, Molecular genetics and metabolism.

[14]  G. Cibelli,et al.  Corticotropin‐releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways , 2001, The European journal of neuroscience.

[15]  R. Hauger,et al.  GRK3 mediates desensitization of CRF1 receptors: a potential mechanism regulating stress adaptation. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[16]  J. Spiess,et al.  Inhibition of corticotropin releasing hormone type-1 receptor translation by an upstream AUG triplet in the 5' untranslated region. , 2001, Molecular pharmacology.

[17]  J. Vaughan,et al.  Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Randeva,et al.  Rat cerebral cortex corticotropin‐releasing hormone receptors: evidence for receptor coupling to multiple G‐proteins , 2001, Journal of neurochemistry.

[19]  N. Kalin,et al.  Corticotropin-releasing hormone and animal models of anxiety: gene–environment interactions , 2000, Biological Psychiatry.

[20]  H. Randeva,et al.  Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins. , 2000, Molecular endocrinology.

[21]  T. Horio,et al.  Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart. , 2000, American journal of physiology. Heart and circulatory physiology.

[22]  F. Holsboer,et al.  Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. , 2000, Journal of psychiatric research.

[23]  F. Dautzenberg,et al.  Functional characterization of corticotropin-releasing factor type 1 receptor endogenously expressed in human embryonic kidney 293 cells. , 2000, European journal of pharmacology.

[24]  R. Hauger,et al.  Rapid agonist-induced phosphorylation of the human CRF receptor, type 1: a potential mechanism for homologous desensitization. , 2000, Biochemical and biophysical research communications.

[25]  P. Sawchenko,et al.  Do Centrally Administered Neuropeptides Access Cognate Receptors?: An Analysis in the Central Corticotropin-Releasing Factor System , 2000, The Journal of Neuroscience.

[26]  J. Vaughan,et al.  Urocortin Expression in Rat Brain: Evidence Against a Pervasive Relationship of Urocortin‐Containing Projections With Targets Bearing Type 2 CRF Receptors , 1999, The Journal of comparative neurology.

[27]  S. Heinrichs,et al.  Corticotropin-releasing factor antagonists, binding-protein and receptors: implications for central nervous system disorders. , 1999, Bailliere's best practice & research. Clinical endocrinology & metabolism.

[28]  W. Vale,et al.  Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. , 1999 .

[29]  P. Schoeffter,et al.  Functional, endogenously expressed corticotropin‐releasing factor receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH‐SY5Y cells , 1999, Fundamental & clinical pharmacology.

[30]  R. Hauger,et al.  The ligand‐selective Domains of Corticotropin‐Releasing Factor Type 1 and Type 2 Receptor Reside in Different Extracellular Domains , 1999, Journal of neurochemistry.

[31]  T. Insel,et al.  Autoradiographic and in situ hybridization localization of corticotropin‐releasing factor 1 and 2 receptors in nonhuman primate brain , 1999, The Journal of comparative neurology.

[32]  Fuchs,et al.  Isolation and Pharmacological Characterization of Two Functional Splice Variants of Corticotropin‐Releasing Factor Type 2 Receptor from Tupaia belangeri , 1999, Journal of neuroendocrinology.

[33]  P. Sawchenko,et al.  Ovine genomic urocortin: cloning, pharmacologic characterization, and distribution of central mRNA. , 1999, Brain research. Molecular brain research.

[34]  S. Heinrichs,et al.  Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. , 1999, Current pharmaceutical design.

[35]  F. Holsboer,et al.  The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. , 1999, Journal of psychiatric research.

[36]  J. Hughes,et al.  Corticotropin-Releasing Factor Type 1 and Type 2α Receptors Regulate Phosphorylation of Calcium/Cyclic Adenosine 3',5'-Monophosphate Response Element-Binding Protein and Activation of p42/p44 Mitogen-Activated Protein Kinase. , 1999, Endocrinology.

[37]  Y. Taché,et al.  Peripheral urocortin delays gastric emptying: role of CRF receptor 2. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[38]  D. Luthin,et al.  Synthesis and biological activity of oxo-7H-benzo[e]perimidine-4-carboxylic acid derivatives as potent, nonpeptide corticotropin releasing factor (CRF) receptor antagonists. , 1999, Bioorganic & medicinal chemistry letters.

[39]  W. Vale,et al.  Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. , 1999, The Journal of pharmacology and experimental therapeutics.

[40]  M. Rosenfeld,et al.  Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Kiang,et al.  Corticotropin-releasing factor induces phosphorylation of phospholipase C-γ at tyrosine residues via its receptor 2β in human epidermoid A-431 cells , 1998 .

[42]  E. Fuchs,et al.  Corticotropin-releasing factor receptor type 1 from Tupaia belangeri--cloning, functional expression and tissue distribution. , 1998, European journal of biochemistry.

[43]  M. Choudhry,et al.  Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells , 1998, FEBS letters.

[44]  C. Kemp,et al.  The corticotrophin-releasing factor-binding protein: an act of several parts , 1998, Peptides.

[45]  C. Donaldson,et al.  The structures of the mouse and human urocortin genes (Ucn and UCN). , 1998, Genomics.

[46]  R. Maki,et al.  Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors. , 1997, Molecular endocrinology.

[47]  C. Katona,et al.  Corticotropin-releasing factor binding sites in cortex of depressed suicides , 1997, Psychopharmacology.

[48]  R. Hauger,et al.  Regulation of Corticotropin‐Releasing Factor Receptor Function in Human Y‐79 Retinoblastoma Cells: Rapid and Reversible Homologous Desensitization but Prolonged Recovery , 1997, Journal of neurochemistry.

[49]  Stephen S. G. Ferguson,et al.  Synergistic Regulation of β2-Adrenergic Receptor Sequestration: Intracellular Complement of β-Adrenergic Receptor Kinase and β-Arrestin Determine Kinetics of Internalization , 1997 .

[50]  J. Licinio,et al.  Stress system abnormalities in melancholic and atypical depression: molecular, pathophysiological, and therapeutic implications. , 1996, Molecular psychiatry.

[51]  T. Lovenberg,et al.  Corticotrophin-releasing factor receptors: from molecular biology to drug design. , 1996, Trends in pharmacological sciences.

[52]  D. Grigoriadis,et al.  Homologous desensitization of human corticotropin-releasing factor, receptor in stable transfected mouse fibroblast cells , 1996, Brain Research.

[53]  David Lovejoy,et al.  Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor , 1995, Nature.

[54]  E. De Souza,et al.  Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[55]  T. Lovenberg,et al.  CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. , 1995, Endocrinology.

[56]  E. D. De Souza,et al.  Corticotropin-releasing factor receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and northern blot analysis data. , 1994, Endocrinology.

[57]  A. Baba,et al.  Corticotropin-releasing factor stimulates Ca2+ influx in cultured rat astrocytes. , 1994, Biochemical and biophysical research communications.

[58]  W. Vale,et al.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin , 1981 .

[59]  M. Yaspo,et al.  Molecular cloning and characterization of the Fugu rubripes MEST/COPG2 imprinting cluster and chromosomal localization in Fugu and Tetraodon nigroviridis , 2004, Chromosome Research.

[60]  A. Abou-Samra,et al.  Characterization of Three Corticotropin-Releasing Factor Receptors in Catfish: A Novel Third Receptor Is Predominantly Expressed in Pituitary and Urophysis*† * The nucleotide sequences reported in this paper have been submitted to the GenBank database with accession numbers cfCRF-R1, AF229359; cfCRF , 2001, Endocrinology.

[61]  M. Wright,et al.  Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences. , 2001, The Journal of pharmacology and experimental therapeutics.

[62]  R. Hauger,et al.  Regulation of the Stress Response by Corticotropin-Releasing Factor Receptors , 2000 .

[63]  Marc E. Freeman,et al.  Neuroendocrinology in Physiology and Medicine , 2000, Humana Press.

[64]  S. Heinrichs,et al.  Chapter 2. Recent Progress in Corticotropin-Releasing Factor Receptor Agents , 1999 .

[65]  C. Nemeroff,et al.  The role of corticotropin-releasing factor in depression and anxiety disorders. , 1999, The Journal of endocrinology.

[66]  L. Bilezikjian,et al.  Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. , 1996, Endocrinology.

[67]  S. L. Stevens,et al.  IL-1 a and TNF a DownRegulate CRH Receptor-2 mRNA Expression in the Mouse Heart , 2001 .